1Rungoe C, Langholz E, Andersson M, et al. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011 [ J ]. Gut, 2014, 63 (10) : 1607-1616.
2Kaplan GG, Seow CH, Ghosh S, et al. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study [ J]. Am J Gastroenterol, 2012, 107 (12) : 1879-1887.
3Nakase H, Honzawa Y, Toyonaga T, et al. Diagnosis and treatment of ulcerative colitis with cytomegalovirus infection: importance of controlling mucosal inflammation to prevent cytomegalovirus reactivation[J]. Intest Res, 2014, 12( 1 ) :5-11.
4Roblin X, Pillet S, Oussalah A, et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis [ J ]. Am J Gastmenterol, 2011, 105( 11 ) :2001-2008.
5Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease : controversies, consensus, and implications[ J]. Gut, 2006, 55 (6) :749-753.
6Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trlal[J]. Br Med J, 1955, 2 (4947) : 1041- 1048.
7Matsuoka K, Iwao Y, Moil T, et al. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients [ J ]. Am J Gastroenterol, 2007, 102 ( 2 ) : 331- 337.
8Zeng Z, Zhu Z, Yang Y, et al. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study [ J ]. J Gastroenterol Hepatol, 2013, 28 (7) : 1148-1153.
9Zhao J, Ng SC, Lei Y, et al. First prospective, population-based inflammatory bowel disease incidence study in Mainland of China : the emergence of "Western" disease [ J ]. Inflamm Bowel Dis, 2013,19(9) :1839-1845.
10Yang H, Li Y, Wu W, et al. The incidence of inflammatory bowel disease in Northern China: a prospective population-based study[J]. PLoS One, 2014, 9(7):e101296.
